Canary Foundation-supported biostatistician will work on validating biomarkers for prostate cancer prognosis
Aug. 1, 2011
The Fred Hutchinson Cancer Research Center’s Dr. Ziding Feng has won a 1.2 million grant for prostate cancer studies from the U.S. Department of Defense‘s United States Army Medical Research Acquisition Activity. Feng is one of three Canary Foundation Prostate Team researchers awarded a total of $2.25 million in DOD grants.
150 researchers came to the Center to discuss diet, exercise and obesity's relationship to cancer survival
Oct. 12, 2009
| By Colleen Steelquist
A first-ever conference focused on the relationship of diet, physical activity and obesity to cancer survivorship and prognosis brought 150 attendees from around the world to the Fred Hutchinson Cancer Research Center last week.
Seattle Cancer Care Alliance physicians design University of Washington-based study to examine association between age at prostate-cancer diagnosis and health outcomes
June 8, 2009
To investigate the impact of age on prostate-cancer prognosis, Drs. Daniel Lin and Bruce Montgomery of the Seattle Cancer Care Alliance and University of Washington colleague Michael Porter designed a study at the UW to examine the association between age at diagnosis and health outcomes in men diagnosed with prostate cancer in the U.S.
Markers for inflammation discovered in breast-cancer survivors are linked to survival
June 1, 2009
| By Dean Forbes
Fred Hutchinson Cancer Research Center-led research has identified two proteins in the blood that could become important prognostic markers for long-term survival in breast-cancer patients. The proteins are associated with chronic inflammation, which is known to contribute to cancer development and progression.